Michael Kassiou - Concepedia

Author

Michael Kassiou

The University of Sydney ORCID

Also Known As

Kassiou M., Kassiou, M., Kassiou, Michael, M Kassiou, M. KASSIOU, M. Kassiou, Michael Kassiou, Mickael Kassiou

405

Publications

13.8K

Citations

H-Index

172

Concepts

All Affiliations

The University of Sydney Macquarie University Royal Prince Alfred Hospital Commissariat à l'Énergie Atomique et aux Énergies Alternatives Inserm

About

Michael Kassiou is an author at The University of Sydney specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	88	4.5K
2	Natural Sciences	21	35	1.6K
3	Social Sciences	11	13	612
4	Health Sciences	8	8	682
5	Engineering	7	7	189

Michael Kassiou

184

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, Science Signaling Biased AgonismOpioid EpidemicPain MedicineMolecular PainLow Intrinsic Efficacy	2020	350
DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization Michelle L. James, Roger Fulton, Johnny Vercoullie, Journal of Nuclear Medicine	2008	268
Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues Samuel D. Banister, Mitchell Longworth, Richard C. Kevin, ACS Chemical Neuroscience	2016	246
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study Jennifer M. Coughlin, Yuchuan Wang, Cynthia A. Munro, Neurobiology of Disease Former Nfl PlayersMedicineVivo MultimodalNeuroimagingBrain Injury	2014	241
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA Samuel D. Banister, Michael Moir, Jordyn Stuart, ACS Chemical Neuroscience Cannabis UseMedicinal ChemistryDrug TargetPsychoactive DrugPharmacological Study	2015	239
Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis Philippe Corcia, Clovis Tauber, Johnnie Vercoullie, PLoS ONE	2012	236
Comparative Evaluation of the Translocator Protein Radioligands <sup>11</sup>C-DPA-713, <sup>18</sup>F-DPA-714, and <sup>11</sup>C-PK11195 in a Rat Model of Acute Neuroinflammation Fabien Chauveau, Nadja Van Camp, Frédéric Dollé, Journal of Nuclear Medicine	2009	225
Brain inflammation is induced by co-morbidities and risk factors for stroke Caroline Drake, Hervé Boutin, Matthew Jones, Brain Behavior and Immunity	2011	203
Evaluation of the PBR/TSPO Radioligand [<sup>18</sup>F]DPA-714 in a Rat Model of Focal Cerebral Ischemia Abraham Martín, Raphaël Boisgard, Benoît Thezé, Journal of Cerebral Blood Flow & Metabolism Focal Cerebral IschemiaRat ModelSocial SciencesCerebral Vascular RegulationNeuroinflammation	2009	198
Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 Samuel D. Banister, Jordyn Stuart, Richard C. Kevin, ACS Chemical Neuroscience Drug TargetPharmacotherapyExperimental PharmacologyCannabinoid PharmacologyPharmaceutical Chemistry	2015	194

Page 1